Cell Death and Disease (Apr 2022)

Anti-apoptotic HAX-1 suppresses cell apoptosis by promoting c-Abl kinase-involved ROS clearance

  • Qincai Dong,
  • Dapei Li,
  • Huailong Zhao,
  • Xun Zhang,
  • Yue Liu,
  • Yong Hu,
  • Yi Yao,
  • Lin Zhu,
  • Guang-Fei Wang,
  • Hainan Liu,
  • Ting Gao,
  • Xiayang Niu,
  • Tong Zheng,
  • Caiwei Song,
  • Di Wang,
  • Yu Bai,
  • Jing Jin,
  • Zijing Liu,
  • Yanwen Jin,
  • Ping Li,
  • Cheng Cao,
  • Xuan Liu

DOI
https://doi.org/10.1038/s41419-022-04748-2
Journal volume & issue
Vol. 13, no. 4
pp. 1 – 14

Abstract

Read online

Abstract The anti-apoptotic protein HAX-1 has been proposed to modulate mitochondrial membrane potential, calcium signaling and actin remodeling. HAX-1 mutation or deficiency results in severe congenital neutropenia (SCN), loss of lymphocytes and neurological impairments by largely unknown mechanisms. Here, we demonstrate that the activation of c-Abl kinase in response to oxidative or genotoxic stress is dependent on HAX-1 association. Cellular reactive oxygen species (ROS) accumulation is inhibited by HAX-1-dependent c-Abl activation, which greatly contributes to the antiapoptotic role of HAX-1 in stress. HAX-1 (Q190X), a loss-of-function mutant responsible for SCN, fails to bind with and activate c-Abl, leading to dysregulated cellular ROS levels, damaged mitochondrial membrane potential and eventually apoptosis. The extensive apoptosis of lymphocytes and neurons in Hax-1-deficient mice could also be remarkably suppressed by c-Abl activation. These findings underline the important roles of ROS clearance in HAX-1-mediated anti-apoptosis by c-Abl kinase activation, providing new insight into the pathology and treatment of HAX-1-related hereditary disease or tumorigenesis.